Pharmaceutical naming is extremely complex, given regulatory and legal constraints and parameters. The world’s most innovative and respected pharmaceutical companies continuously trust our brand creation agency and name safety partner, SafeMark, for proprietary, non-proprietary, and clinical trial verbal and visual branding. When you partner with us, you’re in great company, and joining a team with more than 220 years of combined leadership expertise in the pharmaceutical and healthcare sector.
WHY WE’RE DIFFERENT
DECADES OF INDUSTRY EXPERTISE
With 200,000 drugs on the market and more than 1.3 million registered trademarks in Class 5, pharmaceutical naming has never been more elaborate. The difference of one letter could lead to a drug being mistakenly prescribed, resulting in patient harm, or even death. Our senior leadership team, with decades of pharmaceutical branding experience to their name, works directly on your project to navigate these hurdles and deliver creative, screened, and tested names and confidence.
NO NAMING DATABASES
Your brand isn’t cookie cutter, and we don’t utilize a previously concepted bank of names to pull from for your project. Our global team of brand naming experts approaches each project individually, to develop original, inventive ideas that are specific to you, your brand, your drug attributes, and your goals. We’re all about recycling, but not for the work we do for clients.
TRADEMARK PARALEGALS ON STAFF
Our team includes trademark paralegals who screen and vet each candidate we show to you. We want to make sure we are only putting viable options in front of your team and take the necessary steps up front to do so.
TRADEMARK & POCA ANALYSIS
Our paralegals employ a combination of tools that include 268 international trademark databases, along with Pharma-In-Use Legal Prescreen (Corsearch®) and Common-Law Prescreen. Name candidates are also screened with the FDA POCA system to assure that no presented options exceed a 75% threshold in combined Phonetic and Orthographic score.
GLOBAL LINGUISTICS EVALUATION
The world will likely be your stage, and making sure your brand is received well in every market you’ll enter is our top priority. This thorough evaluation is conducted in your 10 identified primary language markets, with in-country, native language-speaking professionals, to ensure the names communicate the correct messaging across all geographic regions.
UNPARALLELED NAME SAFETY TESTING
The Brandsymbol Regulatory Division is the industry-leader in robust and comprehensive regulatory consulting, safety testing, and package and label services for the pharmaceutical and healthcare industries.
IN IT UNTIL YOU WIN IT
We guarantee a partnership until the name is approved for your compound. Period.
A track record of success
We’ve created more than 122 healthcare brand identities…and we’re not looking to slow down any time soon. We want to be your pharmaceutical branding agency.
PHARMACEUTICAL BRANDING SUCCESS STORIES
WE’RE BUILDING BOLD BRANDS FOR OUR PHARMACEUTICAL PARTNERS
Pharma Branding Knowledge:

The 12 Brand Archetypes: The Innocent
Definition and characteristics The Innocent archetype represents purity, simplicity, and optimism. Brands embodying this archetype strive to create a sense of safety and positivity, appealing to consumers’ desire for simplicity and goodness. The Innocent is

The 12 Archetypes in Brand Identity
The 12 Archetypes are powerful tools for building and strengthening emotional connections with end users. They represent underlying narratives that deeply resonate with people, tapping into universal themes and shared human experiences. The concept of

The Hidden Costs of Poor Pharma Naming Management
Naming is one of the most critical—and deceptively complex—steps in preparing for market success. The stakes are enormous: regulatory rejections or poorly managed processes can cost your team hundreds of thousands of dollars and delay

Essential Trademark Prescreening During Name Creation
The Importance of Trademark Prescreening in Pharmaceutical Naming Projects Naming a pharmaceutical product is a complex and critical task that extends far beyond creativity and branding. In the pharmaceutical industry, trademark prescreening is an essential

CHMP Highlights: Drug Brand Naming for Emerging Medicines
The recent Committee for Medicinal Products for Human Use (CHMP) meeting, held October 14-17, 2024, showcased significant advancements in various therapeutic categories with the approval of ten new medicines, including the following: Alhemo (concizumab) Korjuny

Video: 10 Steps to a Nonproprietary Name
Time is of the essence in drug development. This video will equip you with the essential knowledge to navigate the nonproprietary naming process for branding your Phase 1 and 2 assets. Watch to: Understand